Related Experiment Video
Updated: Apr 5, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.4K
Misconceptions and Facts About Hypertrophic Cardiomyopathy.
Edgar Argulian1, Mark V Sherrid2, Franz H Messerli1
1Mt Sinai St. Luke's and Roosevelt Hospitals, New York, NY.
The American Journal of Medicine
|August 25, 2015
Summary
Hypertrophic cardiomyopathy, a common genetic heart disease, is often misdiagnosed but is highly treatable. Early diagnosis and proper management significantly improve patient symptoms and survival rates.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic heart condition.
- Historically viewed as untreatable, contemporary advancements have transformed its prognosis.
- HCM is known for its diverse and often misleading clinical presentations.
Purpose of the Study:
- To address common misconceptions surrounding hypertrophic cardiomyopathy.
- To emphasize the importance of prompt diagnosis and effective management.
- To enhance provider awareness of HCM as a treatable condition.
Main Methods:
- This review synthesizes current understanding of hypertrophic cardiomyopathy.
- It highlights diagnostic challenges and common misdiagnoses.
- It discusses modern therapeutic strategies and their impact on outcomes.
Main Results:
- Hypertrophic cardiomyopathy is frequently misdiagnosed, often presenting as asthma, anxiety, mitral valve prolapse, or coronary artery disease.
- Despite diagnostic delays, effective management strategies exist.
- Properly diagnosed and treated patients experience improved symptoms and survival.
Conclusions:
- Hypertrophic cardiomyopathy is a highly treatable genetic heart disease, not a relentless condition.
- Increased provider awareness is crucial for timely diagnosis and effective management.
- Addressing misconceptions can lead to better patient care and outcomes.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
732
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
01:25Cardiomyopathy I: Introduction and Classification
824
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
824
01:29Cardiomyopathy V: Interprofessional Care
656
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
01:30Cardiomyopathy II: Dilated Cardiomyopathy
772
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
01:29Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
01:17Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K